ライフサイエンスコーパス: autoinjector

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します

1 y of life compared to carrying an adrenaline autoinjector.

2 f which 10% were treated with an epinephrine autoinjector.

3 Many with wheeze did not use their autoinjector.

4 of supporting measures and lack of antidotal autoinjectors.

5 as shown patients commonly misuse adrenaline autoinjectors (AAI).

6 Patients already prescribed adrenaline autoinjectors (AAIs) for anaphylaxis were examined with

7 The number of adrenaline autoinjectors activated per 1000 students at risk of ana

8 However, adrenaline autoinjector activation has remained fairly stable despi

9 Although autoinjectors allow faster access to epinephrine for ana

10 c children who were prescribed an adrenaline autoinjector and to assess whether it was used appropria

11 Additionally, authors discuss epinephrine autoinjectors and the various routes of epinephrine admi

12 to be at risk for suboptimal treatment when autoinjectors are used.

13 (at least for 2 h), and carry an adrenaline autoinjector at all times.

14 No epinephrine autoinjectors contain an optimal dose for infants weighi

15 e risk of severe anaphylaxis, development of autoinjectors containing a 0.1-mg epinephrine dose suita

16 rers are unsure when to use their adrenaline autoinjectors, contributing to a low quality of life and

17 so less likely to have filled an epinephrine autoinjector (EAI) prescription or visited an allergist/

18 relies on allergen avoidance and epinephrine autoinjector for rescue treatment in patients at risk of

19 ry an emergency kit containing an adrenaline autoinjector, H1 -antihistamines, and corticosteroids de

20 vels and the annual usage rate of adrenaline autoinjectors in the school setting relative to the numb

21 These results suggest that the autoinjector is often not used appropriately after presc

22 Based on limited data, the Mark 1 autoinjector kit (Meridian Medical Technologies, Columbi

23 41 patients with anaphylaxis who used their autoinjector needed another dose of adrenaline.

24 the study medication by either intramuscular autoinjector or intravenous infusion.

25 included fear of use, unavailability of the autoinjector, prior improvement with use of an oral anti

26 here has been a debate about when adrenaline autoinjectors should be prescribed and how many should b

27 agent antidotes are available in prepackaged autoinjectors that can be delivered rapidly following an

28 Similarly, rates of adrenaline autoinjector usage in the school environment have yet to

29 more effective guidance on proper adrenaline autoinjector use.

30 An adrenaline autoinjector was prescribed to 139 food allergic childre

31 An adrenaline autoinjector was used by 41 (16.7%, 95% CI: 11.7-21.3) p

32 hylaxis after the prescription; however, the autoinjector was used in only six (25%) of those cases.

33 on were analyzed, as was whether and how the autoinjector was used.

34 c children who were prescribed an adrenaline autoinjector were investigated.

35 of adult formulated atropine and pralidoxime autoinjectors will deliver doses above current recommend

WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。